Isolated Central Epiretinal Membrane: A Rare Complication of Fovea-Sparing Internal Limiting Membrane Peeling Technique

Yen-Chih Chen, San-Ni Chen, Yen-Chih Chen, San-Ni Chen

Abstract

Purpose: To report a rare complication presenting as an isolated central epiretinal membrane (ERM) related to fovea-sparing internal limiting membrane (ILM) peeling technique.

Methods: Five patients who received fovea-sparing ILM peeling were enrolled. Postoperatively, an isolated central ERM developed. Optical coherence tomography (OCT) was used to evaluate the serial anatomic change.

Results: Among the five included patients, one patient had high myopia with foveoschisis, two patients had vitreomacular traction, and two patients had proliferative diabetic retinopathy with tractional retinal detachment and a fovea cyst. With an average of 5.80 months, OCT showed the gradual development of the isolated central ERM with severe fovea distortion. Four patients received secondary revision surgery, with improvement of the fovea contour and visual acuity.

Conclusion: The fovea-sparing ILM peeling technique may cause a rare but serious complication as the isolated central ERM, which would cause significant fovea distortion as well as visual deterioration. Timely detection and intervention is recommended to prevent further visual loss. This trial is registered with NCT04445142.

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this article.

Copyright © 2021 Yen-Chih Chen and San-Ni Chen.

Figures

Figure 1
Figure 1
Example of the isolated central epiretinal membrane (ERM) development after fovea-sparing internal limiting membrane (ILM) peeling technique in a case with myopic foveoschisis (case 2). (a) A 10-year-old boy had pathologic myopia and macular foveoschisis of the left eye. The best-corrected visual acuity of his left eye was 20/80. He received vitrectomy with fovea-sparing ILM peeling. (b) Postoperatively, the foveoschisis improved. (c) However, 3 months later, an isolated central fovea ERM gradually developed, and optical coherence tomography (OCT) demonstrated severe contraction of the ERM with bulging fovea contour. The central fovea thickness (CFT) was 404 µm, and his visual acuity deteriorated to 20/100. (d) 1 month later, follow-up OCT showed spontaneous peeling of the central ERM with decreased fovea distortion. The CFT improved to 204 µm, and the second revision surgery was therefore postponed.
Figure 2
Figure 2
Example of the isolated central epiretinal membrane (ERM) development after fovea-sparing internal limiting membrane (ILM) peeling technique in a case with proliferative diabetic retinopathy with a fovea cyst (case 5). (A) A 39-year-old male patient had proliferative diabetic retinopathy and a fovea cyst with very thin fovea tissue. He received vitrectomy due to persistent macular edema despite several antivascular endothelial growth factor injections. During vitrectomy, concerning the very thin fovea tissue, we performed fovea-sparing ILM peeling to prevent inadvertent avulsion of fovea tissue. However, after the surgery, optical coherence tomography (OCT) showed the development of isolated central ERM formation with progression 1 month (B) and 3 months (C) later. The central fovea thickness (CFT) was 569 µm, and his visual acuity deteriorated to 20/400. We arranged second surgery to remove the central ERM and residual fovea ILM. (D) After second surgery, OCT showed improvement in fovea contour. Three months after the revision surgery, the CFT improved to 440 µm, and his visual acuity was 20/100.

References

    1. Yamamoto T., Akabane N., Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. American Journal of Ophthalmology. 2001;132(3):369–377. doi: 10.1016/s0002-9394(01)01050-9.
    1. Lois N., Burr J., Norrie J., et al. Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Investigative Opthalmology & Visual Science. 2011;52(3):1586–1592. doi: 10.1167/iovs.10-6287.
    1. Ternent L., Vale L., Boachie C., Burr J. M., Lois N. Cost-effectiveness of internal limiting membrane peeling versus no peeling for patients with an idiopathic full-thickness macular hole: results from a randomised controlled trial. British Journal of Ophthalmology. 2012;96(3):438–443. doi: 10.1136/bjophthalmol-2011-300402.
    1. Almony A., Nudleman E., Shah G. K., et al. Techniques, rationale, and outcomes of internal limiting membrane peeling. Retina. 2012;32(5):877–891. doi: 10.1097/iae.0b013e318227ab39.
    1. Shimada N., Sugamoto Y., Ogawa M., Takase H., Ohno-Matsui K. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy. American Journal of Ophthalmology. 2012;154(4):693–701. doi: 10.1016/j.ajo.2012.04.013.
    1. Ho T.-C., Yang C.-M., Huang J.-S., Yang C.-H., Chen M.-S. Foveola nonpeeling internal limiting membrane surgery to prevent inner retinal damages in early stage 2 idiopathic macula hole. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2014;252(10):1553–1560. doi: 10.1007/s00417-014-2613-7.
    1. Ho T.-C., Yang C.-M., Huang J.-S., et al. Long-term outcome of foveolar internal limiting membrane nonpeeling for myopic traction maculopathy. Retina. 2014;34(9):1833–1840. doi: 10.1097/iae.0000000000000149.
    1. Shinohara K., Shimada N., Takase H., et al. Functional and structural outcomes after fovea-sparing internal limiting membrane peeling for myopic macular retinoschisis by microperimetry. Retina. 2019;8
    1. Russo A., Morescalchi F., Gambicorti E., Cancarini A., Costagliola C., Semeraro F. Epiretinal membrane removal with foveal-sparing internal limiting membrane peeling. Retina. 2019;39(11):2116–2124. doi: 10.1097/iae.0000000000002274.
    1. Morescalchi F., Russo A., Gambicorti E., et al. Peeling of the internal limiting membrane with foveal sparing for treatment of degenerative lamellar hole. Retina. 2019;8
    1. Morescalchi F., Russo A., Bahja H., et al. Fovea-sparing versus complete internal limiting membrane peeling in vitrectomy for the treatment of macular holes. Retina. 2019;4
    1. Grewing R., Mester U. Results of surgery for epiretinal membranes and their recurrences. British Journal of Ophthalmology. 1996;80(4):323–326. doi: 10.1136/bjo.80.4.323.
    1. Bovey E. H., Uffer S., Achache F. Surgery for epimacular membrane. Retina. 2004;24(5):728–735. doi: 10.1097/00006982-200410000-00007.
    1. Park D. W., Dugel P. U., Garda J., et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology. 2003;110(1):62–64. doi: 10.1016/s0161-6420(02)01440-9.
    1. Gaucher D., Haouchine B., Tadayoni R., et al. Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome. American Journal of Ophthalmology. 2007;143(3):455–462. doi: 10.1016/j.ajo.2006.10.053.
    1. Khaja H. A., McCannel C. A., Diehl N. N., et al. Incidence and clinical characteristics of epiretinal membranes in children. Archives of Ophthalmology. 2008;126(5):632–636. doi: 10.1001/archopht.126.5.632.
    1. Harada C., Harada T., Mitamura Y, et al. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy. Molecular Vision. 2004;10:31–36.
    1. Yoshida S., Kobayashi Y., Nakao S., et al. Differential association of elevated inflammatory cytokines with postoperative fibrous proliferation and neovascularization after unsuccessful vitrectomy in eyes with proliferative diabetic retinopathy. Clinical Ophthalmology. 2017;11:1697–1705. doi: 10.2147/opth.s141821.

Source: PubMed

3
Prenumerera